Antonio M Lacy1, Salvadora Delgado, Oscar A Rojas, Raúl Almenara, Anabel Blasi, Josep Llach. 1. Department of Gastrointestinal Surgery and Centro de Investigaciones Biomédicas Esther Koplowitz, Institut de Malalties Digestives I Metaboliques, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain. alacy@clinic.ub.es
Abstract
BACKGROUND: With available laparoscopic and endoscopic instruments/technology a standard radical sigmoid resection is feasible and safe using transvaginal minilaparoscopic-assisted natural orifice surgery (MA-NOS). METHODS: The intervention was a transvaginal MA-NOS sigmoidectomy in a 78-year-old woman with a sigmoid adenocarcinoma. Maintaining triangulation the surgeon positioned himself at the right side of the patient and used the transvaginal trocar for dissection and stapling of both the inferior mesenteric vessels and the upper rectum. The colonic resection was performed extracorporeally in the conventional fashion and was followed by an intra-abdominal endoscopically assisted stapled anastomosis. RESULTS: Advantages of minimally invasive surgery seemed to be enhanced with this hybrid laparoscopic approach. Postoperative course was uneventful. All oncological principles governing resection and management were accomplished and the pathology examination confirmed a T3N1 lesion. The patient was discharged on the fourth postoperative day. CONCLUSION: Transvaginal MA-NOS radical sigmoidectomy is a feasible and oncologically safe procedure. MA-NOS is a realistic option for avoiding the need of assisting incisions and related morbidity in the laparoscopic resection of large intra-abdominal lesions. Combined hybrid laparoscopic NOS in humans (MA-NOS) currently provides a safe and reliable way of defining future clinical applications and advantages of NOS and NOTES. Additionally, it stimulates the active development and evaluation of the underpinning technologies and instrumentation.
BACKGROUND: With available laparoscopic and endoscopic instruments/technology a standard radical sigmoid resection is feasible and safe using transvaginal minilaparoscopic-assisted natural orifice surgery (MA-NOS). METHODS: The intervention was a transvaginal MA-NOS sigmoidectomy in a 78-year-old woman with a sigmoid adenocarcinoma. Maintaining triangulation the surgeon positioned himself at the right side of the patient and used the transvaginal trocar for dissection and stapling of both the inferior mesenteric vessels and the upper rectum. The colonic resection was performed extracorporeally in the conventional fashion and was followed by an intra-abdominal endoscopically assisted stapled anastomosis. RESULTS: Advantages of minimally invasive surgery seemed to be enhanced with this hybrid laparoscopic approach. Postoperative course was uneventful. All oncological principles governing resection and management were accomplished and the pathology examination confirmed a T3N1 lesion. The patient was discharged on the fourth postoperative day. CONCLUSION: Transvaginal MA-NOS radical sigmoidectomy is a feasible and oncologically safe procedure. MA-NOS is a realistic option for avoiding the need of assisting incisions and related morbidity in the laparoscopic resection of large intra-abdominal lesions. Combined hybrid laparoscopic NOS in humans (MA-NOS) currently provides a safe and reliable way of defining future clinical applications and advantages of NOS and NOTES. Additionally, it stimulates the active development and evaluation of the underpinning technologies and instrumentation.
Authors: Anthony N Kalloo; Vikesh K Singh; Sanjay B Jagannath; Hideaki Niiyama; Susan L Hill; Cheryl A Vaughn; Carolyn A Magee; Sergey V Kantsevoy Journal: Gastrointest Endosc Date: 2004-07 Impact factor: 9.427
Authors: S V Kantsevoy; B Hu; S B Jagannath; C A Vaughn; D M Beitler; S S C Chung; P B Cotton; C J Gostout; R H Hawes; P J Pasricha; C A Magee; L J Pipitone; M A Talamini; A N Kalloo Journal: Surg Endosc Date: 2006-01-21 Impact factor: 4.584
Authors: Michael F McGee; Michael J Rosen; Jeffrey Marks; Raymond P Onders; Amitabh Chak; Ashley Faulx; Victor K Chen; Jeffrey Ponsky Journal: Surg Innov Date: 2006-06 Impact factor: 2.058
Authors: Heidi Nelson; Daniel J Sargent; H Sam Wieand; James Fleshman; Mehran Anvari; Steven J Stryker; Robert W Beart; Michael Hellinger; Richard Flanagan; Walter Peters; David Ota Journal: N Engl J Med Date: 2004-05-13 Impact factor: 91.245
Authors: Francisco Alba Mesa; Antonio Amaya Cortijo; Jose Manuel Romero Fernandez; Andrzej L Komorowski; Miguel Angel Sanchez Hurtado; Francisco Miguel Sanchez Margallo Journal: Surg Endosc Date: 2011-09-23 Impact factor: 4.584
Authors: Carsten Zornig; Linn Siemssen; Alice Emmermann; Margrit Alm; Hans A von Waldenfels; Conrad Felixmüller; Hamid Mofid Journal: Surg Endosc Date: 2010-12-22 Impact factor: 4.584